Contact Us
Search
Close this search box.

Publications

Curative-intent metastasis-directed therapies for molecularly-defined oligorecurrent prostate cancer: A
prospective phase II trial testing the oligometastasis hypothesis.
Glicksman et al. European Urology, September 2021. doi: 10.1016/j.eururo.2021.02.031.
Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [18F] DCFPYL-PET: comparison to [18F]fluorocholine-PET.
Yang et al. European Journal of Nuclear Medicine and Molecular Imaging Research, January 2021. doi: 10.1186/s13550-020-00735-w.
[18F]DCFPYL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial.
Glicksman et al. BMJ Open, April 2020. doi: 10.1136/bmjopen-2019-035959.
Development of [131I]I-EOE-TPZ and [131I]I-EOE-TPZMO: Novel tirapazamine (TPZ)-based radioiodinated pharmaceuticals for application in theranostic management of hypoxia.
Elsaidi et al. Pharmaceuticals (Basel), January 2019. doi: 10.3390/ph12010003.
18F-Labeled perfluorocarbon droplets for positron emission tomography imaging.
Amir et al. Nuclear Medicine and Biology, November 2017. doi: 10.1016/j.nucmedbio.2017.07.001
Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry.
 Zlitni et al. PLoS One, May 2017. doi: 10.1371/journal.pone.0176958.
Technetium(I) complexes of bathophenanthrolinedisulfonic acid.
Yazdani et al. Inorganic Chemistry, March 2017. doi: 10.1021/acs.inorgchem.6b03058.

Preparation and evaluation of 99mTc-labeled tridentate chelates for pre-targeting using bioorthogonal
chemistry.

Bilton et al. Journal of Visualized Experiments. February 2017. doi:10.3791/55188

Preparation of an 18F-labeled hydrocyanine dye as a multimodal probe for reactive oxygen species.
Al-Karmi et al. Chemistry, January 2017. doi: 10.1002/chem.201604473.
A 99mTc-labelled tetrazine for bioorthogonal chemistry: Synthesis and biodistribution studies with small molecule trans-cyclooctene derivatives.
Vito et al. PLoS One, December 2016. doi: 10.1371/journal.pone.0167425.
Preparation and evaluation of radiolabeled antibody recruiting small molecules that target prostate-specific membrane antigen for combined radiotherapy and immunotherapy.
Genady et al. Journal of Medicinal Chemistry, March 2016. doi: 10.1021/acs.jmedchem.5b01881
(125)I-Tetrazines and inverse-electron-demand Diels-Alder chemistry: A convenient radioiodination strategy for biomolecule labeling, screening, and biodistribution studies.
Albu et al. Bioconjugate Chemistry, January 2016. doi: 10.1021/acs.bioconjchem.5b00609.  
(125)I-Labelled 2-Iodoestrone-3-sulfate: Synthesis, characterization and OATP mediated transport studies in hormone dependent and independent breast cancer cells.
Banerjee et al. Nuclear Medicine and Biology, March 2015. doi: 10.1016/j.nucmedbio.2014.10.011.  
Implementation of multi-curie production of (99m) Tc by conventional medical cyclotrons.
Bénard et al. Journal of Nuclear Medicine, June 2014. doi: 10.2967/jnumed.113.133413.
Preparation and evaluation of fluorine-18-labeled insulin as a molecular imaging probe for studying insulin receptor expression in tumors.
Kim et al. Journal of Medicinal Chemistry, May 2014. doi: 10.1021/jm401020c.
Emulsion reactors: a new technique for the preparation of molecular imaging probes.
Simms et al. Chemistry, May 2012. doi: 10.1002/chem.201200049.  
Triazole Appending Agent (TAAG): A new synthon for preparing iodine-based molecular imaging and radiotherapy agents.
Darwish et al. ACS Medicinal Chemistry Letters. February 2012. doi: 10.1021/ml300003v.  
The synthesis, magnetic purification, and evaluation of 99mTc-labeled microbubbles.
Lazarova et al. Nuclear Medicine and Biology, November 2011. doi: 10.1016/j.nucmedbio.2011.04.008.  
Preparation of technetium-99m bifunctional chelate complexes using a microfluidic reactor: a comparative study with conventional and microwave labeling methods.
Simms et al. Journal of Labelled Compounds and Radiopharmaceuticals, October 2011. doi: 10.1002/jlcr.1946.  
A bridge not too far: Linking disciplines through molecular imaging probes.
Valliant JF. Journal of Nuclear Medicine, August 2010. doi: 10.2967/jnumed. 109.068312.  

Suite 111A
175 Longwood Rd. S.
Hamilton, Ontario, Canada, L8P 0A1

info@cpdc.ca

OUR PARTNERS

Suite 111
175 Longwood Road. S.
Hamilton, Ontario, Canada, L8P 0A1

info@cpdc.ca

Our Partners

© 2024 Centre for Probe Development and Commercialization. All rights reserved. Accessibility

Follow us on